Financial insights of AGIO

MyFinsight

For the quarter ending 2025-09-30, AGIO made $12,880K in revenue. -$103,433K in net income. Net profit margin of -803.05%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Total revenue	12,880	12,455	8,726	8,964
Cost of sales	1,679	1,702	1,085	783
Research and development	86,796	91,940	72,743	72,455
Selling, general and administrative	41,274	45,869	41,527	38,537
Total operating expenses	129,749	139,511	115,355	111,775
Loss from operations	-116,869	-127,056	-106,629	-102,811
Gain on sale of contingent payments	0	-	-	889,136
Milestone payment from gain on sale of oncology business	0	-	-	200,000
Interest income, net	13,369	14,513	16,087	13,059
Other income, net	67	523	1,253	1,651
Net (loss) income before taxes	-103,433	-	-	1,001,035
Income tax expense	0	-	-	53,120
Net (loss) income	-103,433	-112,020	-89,289	947,915

Net (loss) income per share - basic (in usd per share)	-1.78	-1.93	-1.55	16.65
Net (loss) income per share - diluted (in usd per share)	-1.78	-1.93	-1.55	16.22
Weighted-average number of common shares used in computing net (loss) income per share basic (in shares)	58,139,277	57,932,576	57,459,195	56,939,403
Weighted-average number of common shares used in computing net (loss) income per share diluted (in shares)	58,139,277	57,932,576	57,459,195	58,432,796